Drug Stoppages Often Feasible, but Patient Anxiety Can Be a Hurdle

Thomas R. Collins is a freelance writer living in South Florida.

References

George M, Baker J, Winthrop K, et al. Risk of serious infection with long-term use of low-dose glucocorticoids in patients with rheumatoid arthritis [abstract 848]. Arthritis Rheumatol. 2019;71(suppl 10).
Allaart CF, Breedveld FC, Dijkmans BAC, et al. Treatment of recent-onset rheumatoid arthritis: Lessons from the BeSt study. J Rheumatol Suppl. 2007 Nov;80:25–33.
Markusse IM, Dirven L, Gerards AH, et al. Disease flares in rheumatoid arthritis are associated with joint damage progression and disability: 10-year results from the BeSt study. Arthritis Res Ther. 2015 Aug 31;17(1):232.
Heimans L, Wevers-de Boer KVC, Visser K, et al. A two-step treatment strategy trial in patients with early arthritis aimed at achieving remission: The IMPROVED study. Ann Rheum Dis. 2014 Jul;73(7):1356–1361.

Handpicked Reviews of Contemporary Literature

Strategies to identify and track remission in your RA patients

WASHINGTON, D.C.—Clinical aspects of managing patients with rheumatoid arthritis (RA) in remission were discussed by a panel of experts at the 2016 ACR/ARHP Annual Meeting during the session titled Rheumatoid Arthritis—Clinical Aspects IV: Managing Patients in Remission. Among the issues raised were strategies to taper or discontinue biologic therapies, as well as clinical predictors of…

Over the past few years, biosimilars and other new drugs have been introduced to treat rheumatic illnesses. Some of the conditions we treat have numerous drug options, others have few or only off-label options. This series, Rheumatology Drugs at a Glance, provides streamlined information on the administration of biologic, biosimilar and other medications used to…

References

Reading Rheum

Target Remission

Drug Reduction Strategies, Disease Control for Patients with RA in Remission

Rheumatology Drugs at a Glance, Part 1: Psoriatic Arthritis

References

Related Articles